Bio-Rad Laboratories, Inc. (BIO) est une société cotée en bourse dans le Santé secteur, opérant dans le Medical - Devices secteur d'activité. Le siège social de l'entreprise est situé à Hercules, CA, United States. Le PDG actuel est Norman D. Schwartz.
BIO a date d'introduction en bourse 1980-02-27, 7,700 employés à temps plein, cotée sur le NYSE, une capitalisation boursière de $7.99B.
Bio-Rad Laboratories, Inc. is a global manufacturer and distributor of life science research and clinical diagnostic products, serving markets across the United States, Europe, Asia, Canada, and Latin America. The company operates through two primary segments: Life Science, which provides reagents, instruments, and apparatus for research in proteomics, genomics, biopharmaceutical production, and food safety; and Clinical Diagnostics, which develops test systems, informatics software, and quality control products for clinical laboratories and in vitro diagnostics. Bio-Rad serves a diverse customer base including universities, pharmaceutical manufacturers, biotechnology firms, hospital laboratories, and food testing facilities through its direct sales force and network of distributors. Founded in 1952 and headquartered in Hercules, California, the company specializes in products and systems for separating, identifying, analyzing, and purifying complex chemical and biological materials.
